Deep Enhanced Imaging in Stroke and Vascular Neurology

Sponsor
Chinese PLA General Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05614193
Collaborator
(none)
1,000
1
61
16.4

Study Details

Study Description

Brief Summary

To investigate the performance of enhanced computed tomography (CT) or magnetic resonance (MR) imaging by deep learning relative to conventional CT or MR imaging in brain stroke and vascular neurology. We expect that the deep enhanced imaging method can shorten the time stay in the imaging session of stroke patients, optimize the overall imaging quality and improve the patients' care in imaging session.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Deep learning imaging enhancement

Detailed Description

Early diagnosis of cerebral infarction, detection of ischemic penumbra, evaluation of collateral circulation and identification of vascular lesions by imaging are critical for treatment decision and outcome improvement in cerebral stroke. Multimodal computed tomography (CT) and magnetic resonance (MR) imaging are most prevalent and accessible approaches in clinical scenarios. These two approaches are downgraded either by radiation exposure or long scanning time which may hinder the rapid treatment for patients. Deep learning has shown substantial achievements in medical imaging enhancement. The added value of deep learning method in stroke and vascular neurology has not been thoroughly validated. In this study, we aimed to investigate the performance of enhanced computed tomography (CT) or magnetic resonance (MR) imaging by deep learning relative to conventional CT or MR imaging in brain stroke and vascular neurology. We expect that the deep enhanced imaging method can shorten the time stay in the imaging session of stroke patients, optimize the overall imaging quality and improve the patients' care in imaging session.

Study Design

Study Type:
Observational
Anticipated Enrollment :
1000 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Deep Enhanced Imaging in Stroke and Vascular Neurology
Anticipated Study Start Date :
Dec 1, 2022
Anticipated Primary Completion Date :
Dec 31, 2027
Anticipated Study Completion Date :
Dec 31, 2027

Arms and Interventions

Arm Intervention/Treatment
Imaging group

Participants with suspecting brain stroke or vascular lesion conducted conventional CT or MR imaging and deep enhanced imaging.

Diagnostic Test: Deep learning imaging enhancement
Conventional imaging or down-sampling imaging from CT or MR are enhanced by approved deep learning method.

Outcome Measures

Primary Outcome Measures

  1. The performance of deep enhanced imaging in lesion detection and diagnosis [1 year]

    The performance of deep enhanced imaging in lesion detection and diagnosis, including imaging quality, accuracy, sensitivity and specificity in lesion detection and imaging diagnosis.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • suspecting to have experienced stroke or cerebral ischemia and needed to undergo brain imaging and vascular imaging including CT or MRI

  • no history of kidney failure

  • a minimum age of 18 years

  • obtained written informed consent

Exclusion Criteria:
  • severe movement artifacts

  • incidental finding of tumor lesion or craniocerebral surgery history

  • poor imaging failed to perform deep learning method

  • women who pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chinese PLA General Hospital Beijing Beijing China 100853

Sponsors and Collaborators

  • Chinese PLA General Hospital

Investigators

  • Study Chair: Lou Xin, Chinese PLA General Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Xin Lou, Chairman, Chinese PLA General Hospital
ClinicalTrials.gov Identifier:
NCT05614193
Other Study ID Numbers:
  • AI-301
First Posted:
Nov 14, 2022
Last Update Posted:
Nov 14, 2022
Last Verified:
Nov 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Xin Lou, Chairman, Chinese PLA General Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 14, 2022